TMCnet News
Advanced and Targeted Drug Delivery Market to 2021 - Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment - Research and MarketsDUBLIN, July 26, 2016 /PRNewswire/ -- Research and Markets has announced the addition of the "Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021" report to their offering. Advanced and Targeted Drug Delivery Market to grow at a 10.4% CAGR to $319 billion by 2021 from $168 billion in 2016 The advanced and targeted drug delivery market is segmented and analysed through to 2021 with corresponding CAGR breakdown by: - What are the maximum drug release times reported for various nano-based drug carriers? 2.0 Targeted Drug Delivery: An Overview 3.0 Targeted Drug Delivery and Nanomedicines: An Overview 4.0 Lipid-Based Targeted Drug Delivery Nanosystems 5.0 Polymer-Based Carriers for Targeted Drug Delivery 6.0 Polymeric Micelle/Co-Polymers for Targeted Drug Delivery 7.0 Dendrimer-Based Targeted Drug Delivery 8.0 Inorganic Nanoparticles for Targeted Drug Delivery 9.0 Cell-Based Systems for Targeted Delivery 10.0 Nucleic Acid/Peptide as Drug Carriers 11.0 Targeted Therapies by Indication: An Overview 12.0 Other Targeted Drug Delivery Technologies 13.0 Market Analysis to 2021 14.0 Selected Company Profiles Companies Mentioned - 3M Company - Abbott Laboratories - Ablynx NV - Aciont Inc. - Acrux - Agilis Biotherapeutics LLC - Aileron Therapeutics Inc. - Alchemia Oncology Pty Ltd. - Alkermes Pharma Ireland Ltd. - Allergan Inc. - Alnylam Pharmaceuticals - AmpliPhi Biosciences - Andros Pharmaceuticals Co., Ltd. - Angiochem Inc. - Antares Pharma Inc. - Aposense Ltd. - Applied Genetic Technologies Corp. (AGTC) - Aptagen LLC - Aradigm Corp. - ArisGen SA - Armagen Technologies Inc. - Arrowhead Research Corp. - Artificial Cell Technologies Inc. - AsclepiX Therapeutics LLC - Asklepios BioPharmaceutical Inc. - Astellas Pharma Inc. - Audentes Therapeutics Inc. - Avalanche Biotechnologies Inc. - Avita Medical Ltd. - Azaya Therapeutics Inc. - Bachem Americas Inc. - Bayer Pharma AG - BBB Therapeutics BV - Bespak Europe Ltd. - Bicycle Therapeutics Ltd. - BigDNA Ltd. - BIND Therapeutics Inc. - BioDelivery Sciences International Inc. - Bioject Medical Technologies Inc. - BioZone Laboratories Inc. - Camurus AB - Celsion Corp. - CeramiSphere Pty Ltd. - Cerulean Pharma Inc. - Chrysalis BioTherapeutics Inc. - Copernicus Therapeutics Inc. - Cornerstone Pharmaceuticals Inc. - CureVac AG - CytImmune Sciences Inc. - DepoMed Inc. - Dicerna Pharmaceuticals - Dimension Therapeutics Inc. - Dipexium Pharmaceuticals Inc. - Discovery Laboratories Inc. - DURECT - EnGeneIC Ltd - Ensysce Biosciences Inc. - EryDel SpA - EryTech Pharma - Esperance Pharmaceuticals Inc. - Exicure Inc. - FIT Biotech Oy - Flamel Technologies S.A. - Generex Biotechnology Corp. - Genetic Immunity Inc. - Genus Pharmaceuticals Ltd. - GenVec Inc. - GlaxoSmithKline LLC - Glide Pharmaceutical Technologies Ltd. - Heron Therapeutics Inc. - Hoffmann-LaRoche Inc. - ICB International Inc. - iCeutica Inc. - ImmusanT Inc. - InDex Pharmaceuticals AB - Immune Design - Immunocore Ltd. - Inovio Pharmaceuticals - Insite Vision Inc. - Insmed Inc. - Intezyne Technologies Inc. - Keystone Nano Inc. - Kowa Pharmaceuticals America Inc. - LipimetiX Inc. - LiPlasome Pharma ApS - Lipocine Inc. - Lipotek Pty Ltd. - Living Cell Technologies Ltd. - MagForce AG - Mankind Pharma Ltd. - Mersana Therapeutics Inc. - Micochips Biotech Inc. - Milo Biotechnology LLC - miRagen Therapeutics Inc. - Mirna Therapeutics Inc. - Miros Polymers Inc. - Moderna Therapeutics Inc. - MultiVir Inc. - Mystic Pharmaceuticals Inc. - Nanobiotix - Nanocarrier Co., Ltd. - Nanocopoeia Inc. - NanoMedical Systems Inc. - NanoOncology Inc. (PeptiMed Inc.) - Nanospectra Biosciences Inc. - Nano Precision Medical Inc. - Nanotherapeutics Inc. - nanoTherics Ltd - Magnefect System - NanoVector Inc. - NanoViricides Inc. - Nektar Therapeutics - Neos Therapeutics Inc. - NeXstar Pharmaceuticals Inc. - NightstaRx Ltd. - NOD Pharmaceuticals Inc. - Nordic Nanovector ASA - Novagali Pharma S.A. - Novasorb Technology - Novartis Pharmaceuticals Corp. - Ocular Therapeutix Inc. - Oncolytics Biotech Inc. - Oxford Biomedica plc - PDS Biotechnology Corp. - PharmaIN Corp. - PhaseRx Inc. - Phico Therapeutics Ltd. - PolyActiva Pty Ltd. - PolyTherics Ltd. - Presage Biosciences Inc. - pSivida Corp. - Pulmatrix Inc. - Quark Pharmaceuticals Inc. - Ra Pharmaceuticals Inc. - RaNA Therapeutics Inc. - RegeneRx Biopharmaceuticals Inc. - Regenxbio Inc. - Renova Therapeutics Inc. - Replicor Inc. - RetroSense Therapeutics LLC - Rexahn Pharmaceuticals Inc. - RJS Biologics LLC - Roche Holding AG - Sarfez Pharmaceuticals Inc. - Savara Inc. - Scintipharma Inc. - Sequus Pharmaceuticals Inc. - Serina Therapeutics Inc. - Serpin Pharma LLC - Silence Therapeutics PLC - Silenseed Ltd. - Sylentis SA - SoluBest Ltd. - Spark Therapeutics - Spheringenics Inc. - Suda Ltd. - Supratek Pharma Inc. - Taiwan Liposome Co. Ltd. - TheraSource LLC - Transgene SA - Valeant Pharmaceuticals International Inc. - Efudex - Vect-Horus S.A.S. - Vectura Group plc - Vical Inc. - Voyager Therapeutics Inc. - WAVE Life Sciences Pvt. Ltd. - Xel Pharmaceuticals - Xenetic Biosciences - Xigen SA - Zealand Pharma AS - Zozano Pharma Corp For more information visit http://www.researchandmarkets.com/research/m3gm88/advanced_and Media Contact: Research and Markets |